Welcome to the Section of Clinical Sciences (SCS) in the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital, now led by Dr. Karen Costenbader. Our mission is to study and determine the causes of rheumatic diseases and their complications, and to develop and test innovative prevention and treatments to improve the lives of those living with these conditions.
Our research conditions of interest include rheumatoid arthritis, systemic lupus erythematosus and related conditions, gout and pseudogout, Lyme disease, osteoporosis, psoriatic arthritis, osteoarthritis. We study biomarkers and risk factors for disease, quality of care, disparities, drug safety and comparative effectiveness, and test strategies for improving care and outcomes. We are a large group of clinical and translational research principal investigators, with many research personnel, fellows and trainees.
We are highly collaborative and located in the new Hale Building for Transformative Medicine at the Brigham and Women’s Hospital, synergizing with strong clinical and research groups in rheumatology, immunology, epidemiology and biostatistics, pulmonary, renal medicine, orthopedics, dermatology, obstetrics and gynecology and others. Bringing together outstanding clinicians and cutting edge scientists, we aim to accelerate breakthroughs and the translation of advances into precision medicine and personalized patient care. We have many excellent and recognized clinical and translational research mentors and are continually accepting new trainees and mentees.